SCHEMBL7192111

SCHEMBL7192111

COc1ccc(C(=O)C=Cc2cc(OC(C)C)ccc2OC(C)C)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.71
KDM4E B2RXH2 1/20 0.63
LMNA P02545 1/20 0.63
MAPT P10636 1/20 0.63
ATM Q13315 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
TNFRSF1A P19438 4/20 0.61
GABRA3 P34903 1/20 0.61
GABRA2 P47869 1/20 0.61
GABRB2 P47870 1/20 0.61
MAOB P27338 2/20 0.58
DPP4 P27487 2/20 0.57
PTPN1 P18031 1/20 0.57
JUN P05412 1/20 0.56
NFKB1 P19838 1/20 0.56
F3 P13726 1/20 0.55
CAPN1 P07384 1/20 0.54
KRAS P01116 1/20 0.53
PDE4A P27815 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7192107 1.00 ABCG2 (0.71) ABCG2KDM4ELMNAMAPTATM
SCHEMBL9114634 0.90 TNFRSF1A (0.62) ABCG2KDM4ELMNAMAPTATM
SCHEMBL9112769 0.90 TNFRSF1A (0.73) ABCG2LMNAMAPTSMN1; SMN2TNFRSF1A
SCHEMBL7187552 0.86 DPP4 (0.57) ABCG2KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL7187555 0.86 DPP4 (0.57) ABCG2KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL9114378 0.86 ABCG2 (0.59) ABCG2KDM4ELMNAMAPTATM
SCHEMBL9114382 0.86 ABCG2 (0.59) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7183730 0.85 ABCG2 (0.54) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7183724 0.85 ABCG2 (0.54) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7185006 0.85 ABCG2 (0.97) ABCG2KDM4ELMNAMAPTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed